Literature DB >> 29313055

Abatacept Improves Skin-score and Reduces Lesions in Patients with Localized Scleroderma: A Case Series.

Simon Wehner Fage1, Kristian Bakke Arvesen, Anne Braae Olesen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29313055     DOI： 10.2340/00015555-2878

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  5 in total

1.  Immunotherapy of systemic sclerosis.

Authors:  Christina G Katsiari; Theodora Simopoulou; Ioannis Alexiou; Lazaros I Sakkas
Journal:  Hum Vaccin Immunother       Date:  2018-07-16       Impact factor: 3.452

Review 2.  Overview of Juvenile localized scleroderma and its management.

Authors:  Suzanne C Li; Rong-Jun Zheng
Journal:  World J Pediatr       Date:  2019-11-30       Impact factor: 2.764

Review 3.  Is biological therapy in systemic sclerosis the answer?

Authors:  Durga Prasanna Misra; Sakir Ahmed; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2020-01-20       Impact factor: 2.631

Review 4.  Autoantibodies in Morphea: An Update.

Authors:  Sangita Khatri; Kathryn S Torok; Emily Mirizio; Christopher Liu; Kira Astakhova
Journal:  Front Immunol       Date:  2019-07-09       Impact factor: 7.561

5.  A Case of Recalcitrant Linear Morphea Responding to Subcutaneous Abatacept.

Authors:  Jordan Talia; Carole Bitar; Yue Wang; Michael L Whitfield; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2021-01-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.